Vital Farms, Inc. (NASDAQ:VITL - Get Free Report) insider Hoven Reena Chauhan Van acquired 2,242 shares of the firm's stock in a transaction dated Tuesday, May 19th. The shares were acquired at an average price of $8.92 per share, with a total value of $19,998.64. Following the acquisition, the insider owned 25,827 shares in the company, valued at approximately $230,376.84. The trade was a 9.51% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at this link.
Vital Farms Stock Down 2.0%
Shares of VITL traded down $0.19 during midday trading on Thursday, hitting $9.24. 3,107,896 shares of the company's stock traded hands, compared to its average volume of 2,756,894. Vital Farms, Inc. has a 1 year low of $7.95 and a 1 year high of $53.13. The firm's fifty day moving average is $12.74 and its 200-day moving average is $23.70. The company has a current ratio of 1.77, a quick ratio of 1.00 and a debt-to-equity ratio of 0.01. The stock has a market capitalization of $395.93 million, a price-to-earnings ratio of 8.88 and a beta of 1.20.
Vital Farms (NASDAQ:VITL - Get Free Report) last issued its quarterly earnings data on Thursday, May 7th. The company reported ($0.03) EPS for the quarter, missing the consensus estimate of $0.09 by ($0.12). The business had revenue of $187.16 million for the quarter, compared to analysts' expectations of $182.40 million. Vital Farms had a net margin of 6.10% and a return on equity of 14.47%. The business's revenue for the quarter was up 15.4% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.37 EPS. As a group, sell-side analysts anticipate that Vital Farms, Inc. will post -0.45 earnings per share for the current year.
Vital Farms News Summary
Here are the key news stories impacting Vital Farms this week:
- Positive Sentiment: Several Vital Farms insiders and directors have recently bought shares, including Glenda Flanagan and Kofi Owusu Amoo-Gottfried, signaling management confidence and a possible belief the stock is undervalued. Article: Glenda Flanagan Purchases 6,100 Shares of Vital Farms NASDAQ: VITL Stock
- Neutral Sentiment: Recent analyst commentary remains mixed, with the consensus still at “Hold,” even as some firms lowered price targets after the company’s latest earnings report. Article: Analysts Offer Insights on Consumer Goods Companies: Archer Daniels Midland (ADM) and Vital Farms (VITL)
- Negative Sentiment: Multiple law firms are actively advertising a securities class action against Vital Farms tied to the May 8, 2025 to February 26, 2026 period, with a key deadline on May 26, which keeps legal risk front and center for investors. Article: INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Vital Farms, Inc. Of Class Action Lawsuit and Upcoming Deadlines - VITL
Hedge Funds Weigh In On Vital Farms
Institutional investors have recently modified their holdings of the stock. Triumph Capital Management purchased a new position in shares of Vital Farms during the 4th quarter valued at about $25,000. Quarry LP purchased a new stake in shares of Vital Farms during the 4th quarter worth about $27,000. Global Retirement Partners LLC boosted its stake in shares of Vital Farms by 4,382.6% during the 4th quarter. Global Retirement Partners LLC now owns 1,031 shares of the company's stock worth $33,000 after acquiring an additional 1,008 shares in the last quarter. PNC Financial Services Group Inc. grew its position in shares of Vital Farms by 225.6% during the 4th quarter. PNC Financial Services Group Inc. now owns 1,452 shares of the company's stock valued at $46,000 after acquiring an additional 1,006 shares during the period. Finally, Caitong International Asset Management Co. Ltd purchased a new position in shares of Vital Farms in the 3rd quarter valued at about $55,000. Hedge funds and other institutional investors own 98.59% of the company's stock.
Wall Street Analyst Weigh In
VITL has been the subject of a number of research analyst reports. Stifel Nicolaus restated a "hold" rating and issued a $10.00 target price (down from $34.00) on shares of Vital Farms in a research note on Friday, May 8th. Benchmark lowered Vital Farms from a "buy" rating to a "hold" rating in a research note on Thursday, February 26th. William Blair restated a "market perform" rating on shares of Vital Farms in a research note on Friday, May 8th. Zacks Research lowered Vital Farms from a "hold" rating to a "strong sell" rating in a research note on Monday, March 2nd. Finally, TD Cowen lowered Vital Farms from a "buy" rating to a "hold" rating and reduced their target price for the stock from $25.00 to $16.00 in a research note on Wednesday, April 8th. Five equities research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and one has assigned a Sell rating to the company's stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and an average target price of $27.33.
Check Out Our Latest Stock Report on VITL
Vital Farms Company Profile
(
Get Free Report)
Vital Farms, traded on the NASDAQ under the symbol VITL, is a U.S.-based food company specializing in pasture-raised egg and dairy products. The company partners with a network of family farms across the United States to produce eggs, butter and related items under a certified humane, pasture-centric farming model. Vital Farms' supply chain emphasizes animal welfare, environmental stewardship and transparent sourcing, appealing to consumers seeking ethically produced, high-quality ingredients.
Founded in 2007 and headquartered in Austin, Texas, Vital Farms began by marketing pasture-raised eggs to health- and ethically minded shoppers.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Vital Farms, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vital Farms wasn't on the list.
While Vital Farms currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.